mrd: a prognostic marker in targeted therapy
Published 4 years ago • 71 plays • Length 3:45Download video MP4
Download video MP3
Similar videos
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
1:37
mrd as a prognostic tool but not for clinical decision-making in multiple myeloma
-
1:59
the role of mrd as a prognostic & predictive biomarker in cll
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
5:18
the value of mrd as a prognostic tool in myeloma
-
2:59
the prognostic and therapeutic implications of mrd in aml
-
6:33
mrd as a tool to discontinue therapy in mm?
-
2:17
mrd: a promising biomarker in multiple myeloma
-
1:49
bringing precision medicine and mrd into clinical strategies
-
5:46
mrd: standardization and application
-
3:48
mrd-driven hsct for all
-
1:03
personalizing aml treatment by targeting mrd mutations
-
1:31
mrd as an endpoint in clinical trials
-
1:23
the value of mrd as a marker for disease eradication in aml
-
1:40
mrd as a marker for depth of remission in cll
-
3:16
developing patient-specific mrd markers for predicting and preventing mds relapse post-sct
-
2:35
an update on mrd assessment and novel techniques used in the treatment of hematological malignancies